DUNN; Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for DUNN; Robert.The latest application filed is for "mrna-mediated immunization methods".
- DUNN; Robert - San Diego CA
- Dunn; Robert - Raleigh NC
- Dunn; Robert - Longwood FL US
- Dunn; Robert - Buena Vista CO
- Dunn; Robert - Towaco NJ
- Dunn; Robert - Bedford MA
- Dunn; Robert - Cheltenham GB2
- Dunn; Robert - Gloucestershire GB
Trademarks
| Patent | Date |
|---|---|
| Mrna-mediated Immunization Methods App 20210283262 - DOMINY; John ; et al. | 2021-09-16 |
| Methods for the production of fermented beverages and other fermentation products Grant 11,008,539 - Sheppard , et al. May 18, 2 | 2021-05-18 |
| Methods For The Production Of Fermented Beverages And Other Fermentation Products App 20180119074 - Sheppard; John ; et al. | 2018-05-03 |
| System And Method For Providing An Adaptive Scenario-based User Experience App 20180053433 - Dunn; Robert | 2018-02-22 |
| Embedding audio device settings within audio files Grant 8,793,005 - Tissier , et al. July 29, 2 | 2014-07-29 |
| Embedding Audio Device Settings Within Audio Files App 20120065750 - Tissier; Douglas ; et al. | 2012-03-15 |
| Compounds Having 5-ht6 Receptor Affinity App 20100152177 - Dunn; Robert ; et al. | 2010-06-17 |
| Compounds having 5-HT6 receptor affinity Grant 7,696,229 - Dunn , et al. April 13, 2 | 2010-04-13 |
| Alkyl-substituted 3' Compounds Having 5-ht6 Receptor Affinity App 20100056531 - Danca; Mihaela Diana ; et al. | 2010-03-04 |
| Acyclic Compounds Having 5-ht6 Receptor Affinity App 20100029629 - Conticello; Richard ; et al. | 2010-02-04 |
| Pyrrolidine-substituted Azaindole Compounds Having 5-ht6 Receptor Affinity App 20100022581 - Danca; Mihaela Diana ; et al. | 2010-01-28 |
| Phosphodiesterase 4 Inhibitors App 20090221661 - Hopper; Allen ; et al. | 2009-09-03 |
| Phosphodiesterase 4 Inhibitors App 20090118270 - Talamas; Francisco Xavier ; et al. | 2009-05-07 |
| 3' Substituted Compounds Having 5-ht6 Receptor Affinity App 20090069337 - Dunn; Robert ; et al. | 2009-03-12 |
| Phosphodiesterase 4 inhibitors Grant 7,495,017 - Hopper , et al. February 24, 2 | 2009-02-24 |
| 4' Substituted Compounds Having 5-ht6 Receptor Affinity App 20080318941 - Dunn; Robert ; et al. | 2008-12-25 |
| Compositions and Methods for Treatment of Psychiatric Disorders App 20080255098 - Dunn; Robert | 2008-10-16 |
| 6' Substituted Compounds Having 5-ht6 Receptor Affinity App 20080200471 - Dunn; Robert ; et al. | 2008-08-21 |
| Compounds having 5-HT6 receptor affinity App 20080039462 - Dunn; Robert ; et al. | 2008-02-14 |
| Phosphodiesterase 4 inhibitors App 20070203197 - Hopper; Allen ; et al. | 2007-08-30 |
| Phosphodiesterase 4 inhibitors Grant 7,226,930 - Hopper , et al. June 5, 2 | 2007-06-05 |
| Phosphodiesterase 4 inhibitors App 20070049611 - Talamas; Francisco Xavier ; et al. | 2007-03-01 |
| Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs App 20050222207 - Schumacher, Richard ; et al. | 2005-10-06 |
| Phosphodiesterase 4 inhibitors App 20040229918 - Hopper, Allen ; et al. | 2004-11-18 |
| Invalid hoist Grant 5,784,729 - Dunn , et al. July 28, 1 | 1998-07-28 |
| Invalid hoist Grant D376,886 - Dunn , et al. December 24, 1 | 1996-12-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 